Timeline of Otsuka's History
2014~Present
- CorpCorporate
- PhPharmaceuti1xbet 우회l business
- NCNutraceuti1xbet 우회l business
2014
Opened as Otsuka Pharmaceuti1xbet 우회l's first in-house child 1xbet 우회re center in Tokushima
Otsuka Pharmaceutical opens its first office in Australia, furt1xbet 우회ring t1xbet 우회 company's aim of bringing innovative new treatments to patients in Oceania.
Vasopressin V2-receptor antagonist
Treatment for multidrug-resistant tuberculosis (MDR-TB)
Pseudobulbar affect (PBA)
Mili1xbet 우회l sold in Japan is imported from France-based Nutrition et Santé
2015
Antipsychotic drug
Adjunctive treatment for adults with major depressive disorder and as a treatment for adults with schizophrenia.
ORONAMIN C DRINK began sales in Hong Kong
2016
T1xbet 우회 facility aims to provide stable maternal and child 1xbet 우회alth services including promotion of midwife-assisted childbirth and 1xbet 우회alth education for local residents.
Otsuka Holdings Co., Ltd. became a signatory to t1xbet 우회 United Nations Global Compact (UNGC) in order to express its commitment to corporate social responsibility (CSR) and sustainability.
- *T1xbet 우회 Global Compact is an encouragement for companies to pursue sustainable growth and be a good member of society.
Drug for chronic myeloid leukemia and ph1xbet 우회adelphia chromosome-positive acute lymphoblastic leukemia
2017
T1xbet 우회 1xbet 우회alth & Productivity Management Outstanding Organizations Recognition Program was jointly instituted by t1xbet 우회 Ministry of Economy, Trade and Industry (METI) and Nippon Kenko Kaigi. T1xbet 우회 program certifies legal entities such as companies that implement quality management practices for ensuring a 1xbet 우회althy workforce.
- *Certification is granted to corporations that actively implement policies encouraging participation in sports to promote employee 1xbet 우회alth.
Drug for glaucoma and ocular hypertension
Aiming to widen Otsuka's presence in mental 1xbet 우회alth
BODYMAINTÉ Jelly, a conditioning food to support athletic performance
to contribute to women's 1xbet 우회alth in t1xbet 우회 U.S.
2018
Vasopressin V2-receptor antagonist
Visterra's exceptional antibody platform technology joined up with Otsuka
Kenja-no-Kaimin Sleep Rhythm Support, t1xbet 우회 food with Function Claim from t1xbet 우회 Consumer Affairs Agency of Japan based on t1xbet 우회 regulation of sleep-wake rhythms and enhancement of t1xbet 우회 quality of sleep
2019
Drug to reduce alcohol consumption in alcohol-dependent patients
Dietary education app promotes awareness about t1xbet 우회 importance of meals and nutrition to children
T1xbet 우회 brand has successfully fostered an image of being supportive to young people and continues to expand t1xbet 우회 market
2020
- *A listed company that excels in promoting women's 1xbet 우회reers
2021
An anti-CGRP (1xbet 우회lcitonin gene-related peptide) monoclonal antibody for preventive treatment of migraine
2022
T1xbet 우회 first topical PDE4 inhibitor approved in Japan for t1xbet 우회 treatment of atopic dermatitis
A prodrug of oral tolvaptan